Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

935.404
-4.350-0.46%
Number of Gainers:6
Number of Losers:10
Number of Flat:1
PE:- -
High:950.312
Open:939.754
Low:922.779
Close:939.754
Volume:490.13M
Turnover:3.58B
Market Cap:629.91B
Float Cap:523.06B

Loading ...

Ping An Healthcare's H1 Earnings Showcase a Leaner Profit Mix as Its Managed Care Model Nears a Full Loop

Stock News
·
Aug 20

Hong Kong Stocks Rise on Thursday on Easing Bond Concerns, Tech Gains; CSPC Pharma Jumps 9%

MT Newswires Live
·
Aug 20

JD Health International Stock Slides 2.2% in Hong Kong

Dow Jones
·
Aug 20

Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 20

AH Share Premium Ranking Update: August 20 Market Close

Stock News
·
Aug 20

Chinese Vaccine Makers Jump on News of Key Success in Cancer Treatment, CanSino Leads

Reuters
·
Aug 20

CSPC Pharma Surges 15% as Moderna's mRNA Cancer Vaccine Hits Key Milestone

Stock News
·
Aug 20

CanSino Biologics Surges Over 35% as Analysts See Parallels with Moderna's Vaccine Platform

Stock News
·
Aug 20

CLSA Says CansinoBio Shares Surge as Moderna's mRNA Cancer Vaccine Succeeds in Late-Stage Trial

Stock News
·
Aug 20

Citi Lifts SBP GROUP Price Target to HK$10.8, Citing Strong H1 Beat

Stock News
·
Aug 20

Hong Kong Stock Movers | Sihuan Pharma Surges Over 6% on Strong H1 Profit Forecast and Expanding Aesthetic Medicine Business

Stock News
·
Aug 20

Historic mRNA Cancer Vaccine Breakthrough Sends Pharmaceutical Stocks Soaring on US, A-share, and HK Markets

Deep News
·
Aug 20

Norway's Vistin Pharma Q2 Revenue Falls on Currency Impact

Reuters
·
Aug 20

CSPC Pharma (01093) Surges Over 12% After Interim Profit Jumps Nearly 1.4-Fold

Stock News
·
Aug 20

CSPC Pharmaceutical Hits 6-Month High on Profit, Dividend Surge

Reuters
·
Aug 20

Finland's Nanoform Q2 Ebitda Loss Narrows on Layoffs, Cost Cuts

Reuters
·
Aug 20

CSPC Pharmaceutical's Attributable Profit More Than Doubles in H1; Shares Jump 14%

MT Newswires Live
·
Aug 20

CSPC Pharma FY26 H1 Profit Attributable to Shareholders More than Doubled to RMB 6.09 Billion; Revenue Rises 40.1% to RMB 18.59 Billion

Reuters
·
Aug 20

CSPC Pharmaceutical Group H1 Net Income Attributable RMB 6,094.2 Million

THOMSON REUTERS
·
Aug 20

CSPC Pharmaceutical Group - Interim Dividend of HK18 Cents Per Share for 2026

THOMSON REUTERS
·
Aug 20